A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

NCT05977322 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped The decision was not based on any safety concerns

Conditions

Pancreatic Ductal Adenocarcinoma
Gastroesophageal Adenocarcinoma
Glioblastoma Multiforme

Interventions

DRUG: 68Ga-FF58
DRUG: 177Lu-FF58

Sponsor

Novartis Pharmaceuticals